Delisted from NASDAQ in Aug 2023
Company logo

ONCS - OncoSec Medical Incorporated

NASDAQ -> Healthcare -> Biotechnology
Pennington, United States
Type: Equity

ONCS price evolution
ONCS
(in millions $) 3 Mar 2023 31 Jan 2023 31 Aug 2022 30 May 2022
Current assets
Cash $3.68 $5.73 $12.3
Short term investments
Net receivables
Inventory
Total current assets $6.44 $8.63 $15.23 $21.14
Long term investments
Property, plant & equipment $1.52 $4.86 $5.64 $5.93
Goodwill & intangible assets $0.34 $0.36 $0.38
Total noncurrent assets $2.43 $5.81 $6.65
Total investments
Total assets $8.87 $14.44 $21.88 $27.99
Current liabilities
Accounts payable $4.69 $4.8 $4.21
Deferred revenue
Short long term debt $1.34 $1.64 $2.05
Total current liabilities $7.23 $6.91 $6.63 $4.69
Long term debt $1.91 $2.13 $3.51 $4.13
Total noncurrent liabilities $7.13 $8.51 $9.13
Total debt $3.46 $5.15 $6.17
Total liabilities $14.36 $15.42 $15.76 $14.11
Shareholders' equity
Retained earnings -$300.88 -$290.65 -$282.37 -$274.15
Other shareholder equity $0.15 $0.9 $0.25 $0.18
Total shareholder equity -$5.49 -$0.98 $6.12
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $12.3 $45.95 $20.35 $25.15
Short term investments
Net receivables
Inventory
Total current assets $15.23 $49.18 $22.82 $28.51
Long term investments
Property, plant & equipment $5.64 $6.37 $6.76 $1.03
Goodwill & intangible assets $0.38 $0.45
Total noncurrent assets $6.65 $7.1 $7.08 $1.38
Total investments
Total assets $21.88 $56.28 $29.9 $29.89
Current liabilities
Accounts payable $4.21 $5.56 $7.92 $4.22
Deferred revenue
Short long term debt $2.05 $2.08 $1.47 $0.08
Total current liabilities $6.63 $7.96 $9.68 $4.98
Long term debt $4.13 $5.24 $6.35
Total noncurrent liabilities $9.13 $10.24 $6.35 $0.64
Total debt $6.17 $7.32 $7.82 $0.08
Total liabilities $15.76 $18.2 $16.03 $5.61
Shareholders' equity
Retained earnings -$285.96 -$251.78 -$206.61 -$164.36
Other shareholder equity $0.25 -$0.08 -$0.02 $0.17
Total shareholder equity $6.12 $38.08 $13.87 $24.28
(in millions $) 3 Mar 2023 31 Jan 2023 31 Aug 2022 30 May 2022
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $7.66 $8.13 $9.55
Operating income
Income from continuing operations
EBIT
Income tax expense $0 $0 -$3.34
Interest expense $0.82 -$0.12 -$0.04
Net income
Net income -$6.86 -$8.22 -$6.25
Income (for common shares)
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $25.82 $34.1 $25.1 $18.45
Selling, general & administrative $11.19 $14.28 $18.31 $11.97
Total operating expenses $37.01 $48.38 $43.22 $29.98
Operating income -$37.01 -$48.38 -$43.22 -$29.98
Income from continuing operations
EBIT -$37.49 -$47.56 -$43.12 -$30.27
Income tax expense -$3.33 -$2.41 -$0.87 $0
Interest expense $0.02 $0.02 $0.01 $0
Net income
Net income -$34.18 -$45.17 -$42.25 -$30.28
Income (for common shares) -$34.18 -$45.17 -$42.25 -$30.28
(in millions $) 3 Mar 2023 31 Dec 2022 31 Aug 2022 30 May 2022
Net income -$6.86
Operating activities
Depreciation $0.01
Business acquisitions & disposals
Stock-based compensation $0.28
Total cash flows from operations -$6.61
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$0.01 -$0.24 -$0.24
Financing activities
Dividends paid
Sale and purchase of stock $3.5
Net borrowings $1.61
Total cash flows from financing $4.16 $4.5 -$1.16 -$0.92
Effect of exchange rate -$0.02 $0.08 -$0.11 -$0.09
Change in cash and equivalents -$8.62 -$2.05 -$33.65 -$26.47
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$34.18 -$45.17 -$42.25 -$30.28
Operating activities
Depreciation $1.07 $1.08 $0.99 $0.24
Business acquisitions & disposals
Stock-based compensation $1.69 $5.6 $4.45 $4.35
Total cash flows from operations -$32.14 -$41.79 -$33.15 -$29
Investing activities
Capital expenditures -$0.24 -$0.3 -$0.01
Investments $23.21
Total cash flows from investing -$0.24 -$0.8 $23.2
Financing activities
Dividends paid
Sale and purchase of stock $0.2 $68.28 $29.98 $28.49
Net borrowings -$1.33 -$0.62 $0.81 -$0.08
Total cash flows from financing -$1.16 $68.21 $28.4 $27.2
Effect of exchange rate -$0.11 -$0.02 -$0.05 -$0.05
Change in cash and equivalents -$33.65 $25.6 -$4.79 $21.34
Fundamentals
Market cap $594.24
Enterprise value N/A
Shares outstanding 2.97M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 2.58
Net debt/EBITDA N/A
Current ratio 0.89
Quick ratio N/A